These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 17125475

  • 1. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
    Zigeuner RE, Hutterer G, Chromecki T, Rehak P, Langner C.
    BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
    [Abstract] [Full Text] [Related]

  • 2. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [Abstract] [Full Text] [Related]

  • 3. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
    Ouzzane A, Colin P, Xylinas E, Pignot G, Ariane MM, Saint F, Hoarau N, Adam E, Azemar MD, Bensadoun H, Cormier L, Cussenot O, Houlgatte A, Karsenty G, Bruyère F, Maurin C, Nouhaud FX, Phe V, Polguer T, Roumiguié M, Ruffion A, Rouprêt M, French Collaborative National Database on UUT-UC.
    Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M.
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [Abstract] [Full Text] [Related]

  • 5. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan.
    Huang PC, Huang CY, Huang SW, Lai MK, Yu HJ, Chen J, Pu YS.
    Int J Urol; 2006 Jul; 13(7):864-9. PubMed ID: 16882044
    [Abstract] [Full Text] [Related]

  • 6. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Chung SD, Huang KH, Lai MK, Huang CY, Chen CH, Pu YS, Yu HJ, Chueh SC.
    Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
    Matsui Y, Utsunomiya N, Ichioka K, Ueda N, Yoshimura K, Terai A, Arai Y.
    Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
    Akao J, Matsuyama H, Yamamoto Y, Hara T, Kawai Y, Sakano S, Ohmi C, Gondo T, Naito K.
    BJU Int; 2008 Aug 05; 102(5):572-5. PubMed ID: 18485032
    [Abstract] [Full Text] [Related]

  • 9. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    J Urol; 2009 Nov 05; 182(5):2177-81. PubMed ID: 19758662
    [Abstract] [Full Text] [Related]

  • 10. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
    Ku JH, Choi WS, Kwak C, Kim HH.
    Urol Oncol; 2011 Nov 05; 29(4):383-7. PubMed ID: 19556154
    [Abstract] [Full Text] [Related]

  • 11. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW, Yates DR, Rehman I, Azzouzi AR, Patterson J, Sibony M, Cussenot O, Hamdy FC.
    J Urol; 2007 May 05; 177(5):1715-20. PubMed ID: 17437794
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S, Mita K, Shigeta M, Usui T.
    Jpn J Clin Oncol; 2007 Apr 05; 37(4):296-301. PubMed ID: 17513309
    [Abstract] [Full Text] [Related]

  • 13. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
    Wright JL, Hotaling J, Porter MP.
    J Urol; 2009 Mar 05; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
    [Abstract] [Full Text] [Related]

  • 14. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
    Hirano D, Okada Y, Nagane Y, Satoh K, Mochida J, Yamanaka Y, Hirakata H, Yamaguchi K, Kawata N, Takahashi S, Henmi A.
    Urol Int; 2012 Mar 05; 89(1):71-7. PubMed ID: 22677699
    [Abstract] [Full Text] [Related]

  • 15. [Urothelial cancer of the upper urinary tract].
    Jurincic-Winkler C, Horlbeck R, Gasser A, Glenewinkel J, Klippel KF.
    Urologe A; 1993 Jul 05; 32(4):295-9. PubMed ID: 8372411
    [Abstract] [Full Text] [Related]

  • 16. Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: a single institutional retrospective long-term follow-up study.
    Takaoka E, Hinotsu S, Joraku A, Oikawa T, Sekido N, Miyanaga N, Kawai K, Shimazui T, Akaza H.
    Int J Urol; 2010 Jul 05; 17(7):623-8. PubMed ID: 20412341
    [Abstract] [Full Text] [Related]

  • 17. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection.
    Huang WW, Huang HY, Liao AC, Shiue YL, Tai HL, Lin CM, Wang YH, Lin CN, Shen KH, Li CF.
    Pathol Int; 2009 Sep 05; 59(9):642-9. PubMed ID: 19712132
    [Abstract] [Full Text] [Related]

  • 18. Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy.
    Abe T, Shinohara N, Harabayashi T, Sazawa A, Akino T, Ishikawa S, Kubota K, Matsuno Y, Osawa T, Shibata T, Toyoda Y, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Takada N, Togashi M, Sano H, Mori T, Nonomura K.
    BJU Int; 2010 Apr 05; 105(8):1102-6. PubMed ID: 19725822
    [Abstract] [Full Text] [Related]

  • 19. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).
    O'Brien T, Ray E, Singh R, Coker B, Beard R, British Association of Urological Surgeons Section of Oncology.
    Eur Urol; 2011 Oct 05; 60(4):703-10. PubMed ID: 21684068
    [Abstract] [Full Text] [Related]

  • 20. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Segura JW, Zincke H, Elliott DS, Blute ML.
    J Urol; 2007 May 05; 177(5):1721-6. PubMed ID: 17437796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.